Brief: Phaserx announces positive safety results from large animal study with hybrid mRNA delivery technology

PZ Wind Down

08/11/2016 13:30

Nov 8 (Reuters) - Phaserx Inc  PZRX.O : 
    * Phaserx Inc - announces positive safety results from large 
animal study with hybrid mRNA delivery technology 
    * Phaserx - administration of mRNA delivered using hybrid 
mRNA technology platform in large animal model was safe, well 
tolerated at all dose levels 
    * Phaserx- Formulation was extremely well tolerated in 
non-human primates with no statistically significant 
dose-related changes in liver enzymes or cytokines 
    * Phaserx Inc - plan to complete IND-enabling studies in 
2017 and initiate human studies of prx-otc in 2018 in OTC 
deficient patients 
 
Source text for Eikon:  ID:nPn3bLYTba  
Further company coverage:  PZRX.O  
 
 ((Bangalore.newsroom@thomsonreuters.com;))